# Trade Mark Journal No.2026/003 16 January 2026

## WO0000001881522 (5,10,42)

Office of origin: United States of America

Date of International Registration:21 August 2025
Date of designation in the UK: 21 August 2025

Class 5
  Diagnostic reagents for medical use; diagnostic reagents for medical imaging; hydrogels for medical purposes; reagents for diagnostic assays, namely cytokine and secretome profiling for medical purposes; reagents for handling and preservation of biological samples for medical use; medical-grade materials for stabilizing and preserving tissue samples.
Class 10
  Medical imaging instruments; microscopes for medical diagnostic use; medical imaging devices for cancer diagnosis and monitoring of cancer treatment; medical instruments used to microscopically image biological samples; optical coherence microscopes for medical diagnostic use; medical instruments used to cut and process tissue samples.
Class 42
  Providing temporary use of non-downloadable software for interpreting the results of medical imaging; providing temporary use of non-downloadable software for interpreting the results of diagnostic assays, namely cytokine and secretome profiling assays; providing temporary use of non-downloadable software for use in interpreting results from multiple diagnostic sources to inform treatment options; providing temporary use of non-downloadable software for obtaining, uploading, and analyzing the results medical imaging and diagnostic assays.

ELEPHAS BIOSCIENCES CORPORATION

Representative: David W. Staple Casimir Jones, S.C., 2275 Deming Way, Ste. 310, Middleton WI 53562, UNITED STATES OF AMERICA